ASX
Clarity Pharmaceuticals Ltd
CU6:ASX•Healthcare
Sensitive ASX Announcement
Recruitment target achieved for Phase II SAR-Bombesin trial
Published: 07/11/23, 09:30am (AEST)•3 pages